In animal models for autosomal dominant Retinitis pigmentosa due to mutations in the RHO gene, recent preclinical findings indicate that treating imbalanced proteostasis by pharmacological inhibition of the VCP/proteasome rescues photoreceptor degeneration (Sen et al., 2021). Here, RHO is linked to autosomal dominant retinitis pigmentosa.